Aspirin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group, (The) (2022) Aspirin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial. The Lancet, 399 (10320). pp. 143-151. ISSN 0140-6736

Abstract

Metadata

Authors/Creators:
  • RECOVERY Collaborative Group, (The)
Copyright, Publisher and Additional Information: © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
Keywords: Adult; Aged; Aged, 80 and over; Aspirin; COVID-19; Female; Hospitalization; Humans; Indonesia; Length of Stay; Male; Middle Aged; Mortality; Nepal; Time Factors; Treatment Outcome; United Kingdom
Dates:
  • Published (online): 17 November 2021
  • Published: 6 January 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 27 Jan 2022 10:39
Last Modified: 27 Jan 2022 10:39
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/S0140-6736(21)01825-0
Related URLs:

Share / Export

Statistics